Clinical Trial Update: Effects of Different Doses of Aspirin on Pathophysiological Markers in Type 2 Diabetes [NA]

View source ↗

Summary

A completed clinical trial update examining the effects of different aspirin doses on pathophysiological markers in individuals with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: University of Portsmouth | Conditions: Diabetes Type 2 | NA | Status: COMPLETED